INREF: AI 评分 51/100 — AI 分析 (4月 2026)

InRetail Perú Corp. operates as a multi-format retailer in Peru, with segments spanning food retail, pharmacies, distribution, shopping centers, and digital commerce. The company's diverse operations and established presence in the Peruvian market contribute to its significant market capitalization.

Key Facts: AI Score: 51/100 Sector: Consumer Cyclical

公司概况

概要：

InRetail Perú Corp. is a multi-format retailer operating primarily in Peru, with a diversified portfolio encompassing food retail, pharmacies, distribution, shopping centers, and digital commerce. The company's strong market position in Peru and its focus on various consumer segments differentiate it within the consumer cyclical sector.

INREF是做什么的？

InRetail Perú Corp., established in 2011 and based in Lima, Peru, has rapidly grown into a leading multi-format retailer within the country. As a subsidiary of Intercorp Retail Inc., InRetail Perú Corp. operates across five key segments: Food Retail, Pharmacies, Distribution, Shopping Center, and Digital. The Food Retail segment includes supermarkets, hypermarkets, discount stores, and cash and carry stores, catering to a wide range of consumer needs. The Pharmacies segment, through its Inkafarma and Mifarma chains, provides drugs, medicines, and cosmetic products. The Distribution segment focuses on distributing drugs, medicines, and consumer products, supporting the company's retail operations. The Shopping Center segment leases commercial stores in shopping centers, contributing to the company's real estate development activities. The Digital segment manages and supports digital commerce services, reflecting the company's adaptation to evolving consumer preferences. InRetail Perú Corp.'s diverse business segments and strategic focus on the Peruvian market have solidified its position as a major player in the consumer cyclical sector.

INREF的投资论点是什么？

InRetail Perú Corp. presents a compelling investment case based on its diversified retail operations and strong market position in Peru. With a P/E ratio of 10.26 and a dividend yield of 2.23%, the company offers a potentially attractive valuation and income stream. Key value drivers include the growth of its digital segment, the expansion of its pharmacy chains, and the continued development of its shopping center portfolio. The company's beta of 0.12 suggests relatively low volatility compared to the broader market. Ongoing catalysts include the increasing consumer spending in Peru and the company's strategic investments in its various business segments. Potential risks include economic fluctuations in Peru and increased competition from other retailers.

INREF在哪个行业运营？

InRetail Perú Corp. operates within the consumer cyclical sector, specifically in the department stores industry. The Peruvian retail market is characterized by increasing consumer spending and a growing middle class. The competitive landscape includes both local and international retailers. InRetail Perú Corp. differentiates itself through its multi-format approach, encompassing food retail, pharmacies, distribution, shopping centers, and digital commerce. The company's focus on the Peruvian market and its diverse business segments position it to capitalize on the growth opportunities within the industry.

Department Stores

Consumer Cyclical

INREF有哪些增长机遇？

Expansion of Digital Commerce: InRetail Perú Corp. has a significant opportunity to expand its digital commerce segment. The increasing adoption of online shopping in Peru, driven by factors such as convenience and accessibility, presents a substantial growth driver. Investments in technology and infrastructure to enhance the online shopping experience can attract a larger customer base. The market size for e-commerce in Peru is projected to grow significantly in the coming years, offering a substantial runway for growth. Timeline: Ongoing.
Growth in Pharmacy Segment: The pharmacy segment, through Inkafarma and Mifarma, represents a key growth opportunity. The increasing demand for healthcare products and services in Peru, driven by an aging population and rising healthcare awareness, supports the expansion of the pharmacy chains. Strategic partnerships with healthcare providers and investments in new store locations can further drive growth. The market size for pharmaceuticals in Peru is expected to continue its upward trajectory. Timeline: Ongoing.
Development of Shopping Centers: The shopping center segment offers growth potential through the development of new shopping centers and the expansion of existing ones. The increasing urbanization and rising disposable incomes in Peru support the demand for modern retail spaces. Strategic location selection and the incorporation of diverse retail offerings can attract a wide range of shoppers. The market size for shopping centers in Peru is expected to grow as the country's economy continues to develop. Timeline: Ongoing.
Strategic Partnerships and Acquisitions: InRetail Perú Corp. can pursue strategic partnerships and acquisitions to expand its market reach and enhance its product offerings. Collaborations with other retailers or technology companies can create synergies and drive innovation. Acquisitions of complementary businesses can strengthen the company's competitive position. The market for mergers and acquisitions in the retail sector is dynamic, offering opportunities for InRetail Perú Corp. to expand its capabilities. Timeline: Ongoing.
Expansion into New Geographies: While primarily focused on Peru, InRetail Perú Corp. could explore opportunities to expand into other Latin American markets. The growing economies and increasing consumer spending in countries such as Colombia and Chile present attractive growth prospects. A careful assessment of market conditions and regulatory environments is essential for successful expansion. The market size for retail in Latin America is substantial, offering a significant opportunity for InRetail Perú Corp. to diversify its revenue streams. Timeline: Future.

Market Cap of $2.85B reflects InRetail Perú Corp.'s significant presence in the Peruvian retail market.
P/E Ratio of 10.26 indicates a potentially attractive valuation compared to industry peers.
Profit Margin of 4.3% demonstrates the company's ability to generate profits from its diverse operations.
Gross Margin of 25.0% highlights the company's efficiency in managing its cost of goods sold.
Dividend Yield of 2.23% provides investors with a steady income stream.

INREF提供哪些产品和服务？

Operates supermarkets and hypermarkets under various brands.
Manages a chain of pharmacies, Inkafarma and Mifarma, offering pharmaceutical products.
Distributes drugs, medicines, and consumer products.
Leases commercial spaces in shopping centers.
Provides digital commerce services.
Engages in real estate development activities.

INREF如何赚钱？

Generates revenue from the sale of food, pharmaceutical products, and consumer goods through its retail stores.
Earns rental income from leasing commercial spaces in shopping centers.
Provides digital commerce services, generating revenue through online sales.
Distributes products to other retailers and businesses, earning revenue through wholesale operations.

Individual consumers purchasing groceries, pharmaceuticals, and other consumer goods.
Retailers and businesses purchasing products through the company's distribution network.
Commercial tenants leasing space in the company's shopping centers.
Online shoppers utilizing the company's digital commerce platforms.

Strong brand recognition and established presence in the Peruvian market.
Diversified business segments providing multiple revenue streams.
Extensive distribution network supporting its retail operations.
Strategic locations of its retail stores and shopping centers.
Integrated supply chain ensuring efficient operations.

什么因素可能推动INREF股价上涨？

Ongoing: Expansion of digital commerce segment to capture online sales growth.
Ongoing: Growth in pharmacy segment driven by increasing healthcare demand.
Ongoing: Development of new shopping centers to capitalize on urbanization.
Ongoing: Strategic partnerships and acquisitions to expand market reach.
Upcoming: Potential expansion into other Latin American markets.

INREF的主要风险是什么？

Potential: Economic downturn in Peru impacting consumer spending.
Ongoing: Increased competition from local and international retailers.
Potential: Changes in government regulations affecting the retail industry.
Potential: Disruptions in the supply chain due to unforeseen events.
Potential: Limited financial disclosure increasing information asymmetry due to OTC listing.

INREF的核心优势是什么？

Diversified business segments providing multiple revenue streams.
Strong brand recognition and established presence in Peru.
Extensive distribution network supporting retail operations.
Experienced management team.

INREF的劣势是什么？

Concentration of operations in Peru, limiting geographic diversification.
Exposure to economic fluctuations in the Peruvian market.
Dependence on key suppliers and distributors.
Potential for increased competition from other retailers.

INREF有哪些机遇？

Expansion of digital commerce segment to capture online sales growth.
Growth in pharmacy segment driven by increasing healthcare demand.
Development of new shopping centers to capitalize on urbanization.
Strategic partnerships and acquisitions to expand market reach.

INREF面临哪些威胁？

Economic downturn in Peru impacting consumer spending.
Increased competition from local and international retailers.
Changes in government regulations affecting the retail industry.
Disruptions in the supply chain due to unforeseen events.

INREF的竞争对手是谁？

Arcos Dorados Holdings Inc — Operates McDonald's restaurants in Latin America. — (ATGSY)
Falabella SA — A major retailer in South America with department stores, home improvement, supermarkets, and financial services. — (FGETF)
Grupo de Narváez — Operates retail businesses in Argentina, Ecuador and Uruguay. — (GDNEF)
Cencosud SA — A South American retailer with supermarkets, home improvement stores, department stores, shopping centers and financial services. — (KNDGF)
Lojas Quero Quero SA — Brazilian chain of construction material stores. — (LGDDF)

Key Metrics

MoonshotScore: 51/100

Company Profile

CEO: Juan Carlos Vallejo Blanco
Headquarters: Panama, PE
Employees: 47,234
Founded: 2019

AI Insight

AI analysis pending for INREF

OTC Tier: OTC Other
Disclosure Status: Unknown

常见问题

What does InRetail Perú Corp. do?

InRetail Perú Corp. operates as a multi-format retailer in Peru, managing a diverse portfolio of businesses. These include supermarkets and hypermarkets under its Food Retail segment, pharmacy chains (Inkafarma and Mifarma) providing pharmaceutical products, a distribution segment for drugs and consumer goods, shopping centers offering commercial spaces for lease, and a digital commerce platform facilitating online sales. This diversified approach allows InRetail to cater to a wide range of consumer needs and leverage synergies across its various business segments, solidifying its position in the Peruvian retail market.

What do analysts say about INREF stock?

AI analysis is pending for InRetail Perú Corp. (INREF). Without analyst consensus, key valuation metrics such as price targets and ratings are unavailable. Investors should conduct their own due diligence, analyzing the company's financial performance, growth prospects, and risk factors. Consider the company's P/E ratio of 10.26, dividend yield of 2.23%, and beta of 0.12, alongside industry trends and competitive dynamics, to form an independent assessment of INREF's investment potential. Monitor for future analyst coverage to gain additional insights.

What are the main risks for INREF?

InRetail Perú Corp. faces several risks inherent to its operations and the Peruvian market. Economic fluctuations in Peru could impact consumer spending and reduce revenue. Increased competition from both local and international retailers could erode market share. Changes in government regulations affecting the retail industry could increase compliance costs. Disruptions in the supply chain due to unforeseen events could impact product availability. Additionally, the company's OTC listing introduces risks related to limited financial disclosure and liquidity.